Target Prices to Control Prescription Drug Spending, AHA Advises

Target Prices to Control Prescription Drug Spending, AHA Advises

By Jacqueline LaPointe July 23, 2018 – With prices, not utilization, driving prescription drug spending at hospitals and health systems, the American Hospital Association (AHA) recently called on policymakers to focus on controlling costs via average sales price (ASP) control. In a letter to the Medicare Payment Advisory Commission (MedPAC), the hospital group pushed for an […]

Malaria drug halts cancer cell survival

A computer illustration of a cancer cell.© Getty Images/iStockphoto / Thinkstock Qatar-based researchers have proposed a way to effectively halt cancer cell production using an existing malaria drug that, they say, can stop proliferation.  The malaria drug, according to the team at Weill-Cornell Medicine in Qatar, could improve the effectiveness of a new class of […]

Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline

Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline

SAN DIEGO, July 23, 2018 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) (“Adamis”) announced today that it has been conducting pre-IND development work for a fast-dissolving sublingual tablet containing tadalafil.  Adamis intends to submit an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) with the goal of filing a New […]

ContraVir Pharma (CTRV) Reports Progress in Phase 1/2A Trial of CRV431

ContraVir Pharma (CTRV) Reports Progress in Phase 1/2A Trial of CRV431

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here. ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of hepatitis B virus (HBV), announced today that it has completed dosing of the first cohort in Part 1 of the Phase […]

Pfizer and GSK's HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

Pfizer and GSK's HIV/AIDS division, ViiV, prevents children with HIV from getting needed medicine

“ViiV needs to recognise its responsibility as today’s only producer of paediatric versions of the new gold standard in treatment for babies and children with HIV, and move mountains to make sure kids can access this treatment immediately,” said Jessica Burry, HIV pharmacist at MSF’s Access Campaign. “A full four years after ViiV first made […]

Anima Biotech Announces an Exclusive Collaboration With Lilly for the Discovery and Development of Translation …

Anima Biotech Announces an Exclusive Collaboration With Lilly for the Discovery and Development of Translation …

BERNARDSVILLE, New Jersey, July 23, 2018 /PRNewswire/ — Anima Biotech today announced an agreement with Lilly for the discovery and development of translation inhibitors for several target proteins by using Anima’s Translation Control Therapeutics platform. The multi-year agreement is structured as an exclusive collaboration around several undisclosed Lilly targets. Anima will use its technology platform to […]

Music for medicine, an exchange of albums for medication in Venezuela

Music for medicine, an exchange of albums for medication in Venezuela

Music for Medicines, a non-profit project campaign urging people to donate medication in exchange for musical albums, kicked off in Caracas last Saturday, aiming to alleviate the consequences of the medicine shortage and the overall healthcare crisis affecting Venezuelans. The project was launched by a group of human rights activists from Venezuelan Education-Action Program on Human Rights […]

Bridge Medicines Enters Agreement with Memorial Sloan Kettering to Develop Kidney-Specific Delivery Platform for the …

NEW YORK, July 23, 2018 /PRNewswire/ — Bridge Medicines announced today an agreement with Memorial Sloan Kettering (MSK) to develop a platform designed to deliver drugs specifically to the kidney.  The first disease target will be acute kidney injury (AKI), a highly prevalent and currently unmet medical need.  This work originated at Memorial Sloan Kettering Cancer […]

Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus

SAN DIEGO and COPENHAGEN, Denmark, July 23, 2018 /PRNewswire/ — Dermtreat, a clinical-stage biopharmaceutical company focused on mucosal diseases, today announced treatment of the first patient in a Phase 2b clinical trial of Rivelin® Clobetasol patch (Rivelin®-CLO) for oral lichen planus (OLP). Rivelin-CLO is the first biodegradable oral adhesive patch designed for local delivery of clobetasol […]

1 2 3 1,278